Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO01404
Host Cell : U87MG Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO01404 |
| Description | This cell line is engineered to stably express Homo sapiens (human) tenascin C (TNC) in Human glioblastoma / glioma cell line (U-87 MG). GFP reporter gene is also expressed in this cell line allowing fluorescent tracking of cells. |
| Product Type | Human gene overexpression stable cell line |
| Target Gene | TNC |
| Gene Species | Homo sapiens (human) |
| Host Cell | U87MG |
| Host Cell Species | Homo sapiens (Human) |
| Reporter | GFP |
| Applications |
1) investigation of gene function 2) screening and validation of antibodies |
| Size | One vial of frozen cells, typically >1x10^6cells/vial |
| Stability | This cell line is stable at least 10 passages. |
| Quality Control |
1) Real-time qPCR analysis of gene mRNA overexpression level 2) GFP fluorescent detection under fluorescent microscopy 3) mycoplasma detection |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Growth Properties | Adherent |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | TNC |
| Gene Symbol | TNC |
| Gene ID | 3371 |
The TNC gene encodes Tenascin-C, a highly conserved and multifunctional glycoprotein of the extracellular matrix. Structurally, Tenascin-C is a massive hexameric molecule composed of assembly domains, epidermal growth factor (EGF)-like repeats, fibronectin type III-like repeats, and a fibrinogen-like globular domain. This intricate structural composition enables it to interact with a diverse array of cell surface receptors, including various integrins, Annexin II, and the epidermal growth factor receptor. Through these varied molecular interactions, the TNC gene plays a profound role in mediating dynamic cellular behaviors—specifically by regulating cell adhesion, stimulating cell proliferation, and promoting directional cell migration. In the field of oncology, the aberrant overexpression of the TNC gene is a hallmark feature of the tumor microenvironment in numerous solid malignancies, particularly in pleomorphic gliomas such as glioblastoma. Within this hostile tumor microenvironment, Tenascin-C functions as a pivotal stromal signaling molecule, facilitating tumor cell invasion, driving pathological angiogenesis, and suppressing local immune surveillance.
To facilitate a comprehensive exploration of the biological functions and therapeutic significance of Tenascin-C in brain tumors, we have meticulously engineered and developed a "Human TNC Stable Expression Cell Line," utilizing the U-87 MG parental cell background as a robust and reliable research model. U-87 MG is a well-characterized and widely utilized human glioblastoma cell line, renowned for its aggressive growth characteristics and its high relevance to human nervous system malignancies. By genetically engineering this specific cell line to stably and constitutively express the human TNC gene, researchers gain access to a standardized experimental platform capable of precisely mimicking the Tenascin-C-rich tumor microenvironment characteristic of high-grade gliomas.
Here, researchers investigated the effects of tendinogen C (TNC) on glioma cell function, paclitaxel chemosensitivity, and the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway. Compared to normal human astrocytes, TNC mRNA and protein expression were increased in glioma cells (including U87, LN-229, U251, and T98G cells). In U87 and U251 cells, TNC promoted cell proliferation and inhibited apoptosis. Furthermore, TNC upregulated the expression of PI3K and p-AKT proteins in U87 and U251 cells. Regarding chemosensitivity, TNC improved the relative survival of U251 cells treated with 400 ng/mL and 800 ng/mL paclitaxel. Regarding stemness, TNC increased the number of spheroids formed per 1000 cells, the percentage of CD44+CD133+ cells, and the 1/stem cell frequency (assessed via limiting dilution analysis) in U251 cells. In the rescue experiment, 740 Y-P reduced the effects of TNC on U251 cell proliferation, apoptosis, chemosensitivity to paclitaxel, and stemness. These results indicate that TNC exerts its carcinogenic effect by regulating the PI3K/AKT signaling pathway, promoting glioma cell proliferation and stemness while inhibiting apoptosis and chemosensitivity to paclitaxel.
In U251 cells, TNC mRNA and protein expression was upregulated in the OE-TNC group compared to the OE-NC group, while it was downregulated in the KD-TNC group compared to the KD-NC group. Similarly, in U87 cells, TNC mRNA and protein expression was increased in the OE-TNC group compared to the OE-NC group, while it was decreased in the KD-TNC group compared to the KD-NC group. These results indicate successful transfection. Further experiments showed that at 48 h and 72 h post-transfection, TNC positively regulated the proliferation of U251 cells (Figure 1a) but negatively regulated apoptosis (Figure 1b, c). Furthermore, at 72 h post-transfection, TNC-overexpressing U87 cells exhibited enhanced proliferation (Figure 1d) and inhibited apoptosis (Figure 1e, f).
Figure 1. Cell proliferation and apoptosis regulated by TNC in glioma cells. (Zhang Q, et al., 2021)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Tenascin-C is critical for our brain tumor modeling, and this U-87 MG stable cell line has been an absolute lifesaver. The extracellular matrix production is evident, and the cells maintain their typical glioblastoma characteristics and growth kinetics.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.